Drug Discovery Informatics Market Analysis And Forecast 2034


The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

What Will Be the Forecast Market Size of the Global Drug Discovery Informatics Market by 2030?
The drug discovery informatics market size has grown rapidly in recent years. It will grow from $4.06 billion in 2025 to $4.63 billion in 2026 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to increasing pharmaceutical r&d complexity, expansion of clinical trial data volumes, adoption of computational chemistry tools, growth in bioinformatics applications, rising demand for faster drug development cycles.

The drug discovery informatics market size is expected to see rapid growth in the next few years. It will grow to $7.74 billion in 2030 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to increasing investments in ai-enabled drug discovery, rising adoption of precision medicine approaches, expansion of collaborative research platforms, growing focus on predictive modeling accuracy, increasing integration of informatics with laboratory systems. Major trends in the forecast period include increasing use of ai-driven drug discovery platforms, rising adoption of cloud-based informatics solutions, growing integration of big data analytics in r&d, expansion of virtual screening and modeling tools, enhanced focus on data integration and management.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

What Are the Key Growth Factors Supporting the Drug Discovery Informatics Market Expansion?
The rising prevalence of various chronic diseases is expected to propel the growth of the drug discovery informatics market going forward. Chronic illnesses are described generically as disorders that persist for a year or longer and need continuing medical treatment, impede everyday activities or both. Drug discovery informatics systems aid in the advancement of chronic illness care by allowing researchers to probe more complex and transient molecular changes that underpin disease progression and drug response, resulting in multi-dimensional models of the entire hierarchical system in healthy, diseased, and treated states. For instance, in May 2024, according to the British Diabetic Association (Diabetes UK), a UK-based patient, healthcare professional, and research charity, around 4.4 million people in the UK were living with a diabetes diagnosis as of 2022-23. Among these cases, approximately 8% had type 1 diabetes, while type 2 diabetes accounted for about 90%. Therefore, the rising prevalence of various chronic diseases is driving the growth of the drug discovery informatics market.

How Is the Drug Discovery Informatics Market Segmented?
The drug discovery informatics market covered in this report is segmented –

1) By Service: In-House, Outsourced
2) By Application: Data Sequencing, Molecular Docking, Identification And Validation, Target Data Analysis
3) By End-User: Pharmaceutical Companies, Contract Research Organizations, Bio-Technology Companies

Subsegments:
1) By In-House: Data Management, Computational Chemistry, Bioinformatics, Cheminformatics, Predictive Modeling
2) By Outsourced: Contract Research Organizations (CROs), Specialized Informatics Providers, Data Analysis And Management Services

What Are the Key Trends Shaping the Drug Discovery Informatics Market?
Major companies operating in the drug discovery informatics market are focusing on innovative products such as AI-powered life sciences solutions to drive revenues in their market. Artificial intelligence (AI)-driven life sciences solutions are advancing precision medicine and drug discovery, with the potential to completely transform the creation of novel therapies and individualized treatment plans to improve the speed, precision, and efficiency of the life sciences industry's research and development procedures. For instance, in May 2023, Google Cloud Platform, a US-based technology company launched AI-powered life sciences solutions, target and lead identification suite, and the multiomics suite. These are intended to revolutionize life sciences companies by speeding up drug research and accelerating the release of new treatments. These methods anticipate protein structures, determine the role of amino acids, and analyze genetic data by utilizing high-performance computers, generative AI, and sophisticated computational tools. Multiomics suite aids in the development of precision medicine tools, the target and lead identification suite facilitate more effective in silico drug design.

Who Are the Top Companies Contributing to the Drug Discovery Informatics Market Expansion?
Major companies operating in the drug discovery informatics market are Accenture Plc.; Certara Inc.; Charles River Laboratories Inc.; Infosys Ltd.; Collaborative Drug Discovery Inc.; Eurofins DiscoverX Products Inc.; Jubilant Biosys Ltd.; Selvita S.A.; PerkinElmer Inc.; International Business Machines Corporation; Boehringer Ingelheim International GmbH; Oracle Corporation; Thermo Fisher Scientific Inc.; Albany Molecular Research Inc.; ChemAxon Ltd.; Amazon Web Services Inc.; Schrödinger LLC.; Core Informatics LLC; Informatics Matters Ltd.; Tata Consultancy Services Limited; Novo Informatics Pvt. Ltd.; IO Informatics Inc.; GVK Biosciences Private Limited; Dassault Systèmes SE; Recursion Pharmaceuticals Inc.; Cyclica Inc.; Valence Discovery Inc.; Valo Health Inc.; Cognizant Technology Solutions Corporation; Wipro Limited; Mindtree Limited; Persistent Systems Limited; Mphasis Limited

Get the full drug discovery informatics market report here:
https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

How does market performance vary across key regions in the Drug Discovery Informatics Market?
North America was the largest region in the drug discover informatics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug discovery informatics market during the forecast period. The regions covered in the drug discovery informatics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034